Rocapine raises US$13m for wellness apps

By Published On: June 17, 2026Last Updated: July 7, 2026
Rocapine raises US$13m for wellness apps

Rocapine has raised US$13m after reaching US$6m ARR in nine months for its wellness app studio.

The Paris-based company says its mission is to turn the smartphone from a source of addiction into a force for wellbeing.

The average person will spend 15 years of their life on a smartphone designed to keep them hooked, or around five hours and 16 minutes a day, according to DataReportal 2025 figures.

Rocapine is building wellness apps designed to do the opposite by helping people build healthier daily habits rather than maximising screen time.

ARR, or annual recurring revenue, is a measure of predictable yearly income from subscriptions or similar recurring payments.

The company said its apps have passed 2.5m downloads, with 70 per cent of revenue coming from the US.

Rocapine said it aims to improve the lives of at least 40m people over the next five years.

The company says a generation is being drained by smartphones.

It said technology had helped people become smarter for decades, citing the Flynn Effect, which refers to the rise in IQ scores seen across generations during much of the 20th century.

Rocapine said that trend has now reversed, with ADHD diagnoses in US children doubling since the 1990s and “brain rot” named Oxford’s Word of the Year for 2024.

“Technology was supposed to make us smarter, healthier and more connected,” said Stanislas Marchand, co-founder and chief executive of Rocapine.

“Instead, too much of it has become addictive, extractive and exhausting. Our phones now track the stress, the sleep loss and the racing heart rates they ironically cause, and still the system pushes us to scroll more. Rocapine was founded to change that.”

The business was founded in late 2024 by Stanislas Marchand, formerly of mobile gaming company Voodoo, Jean-Gabriel Boinot-Tramoni and Sammy Teillet.

The Paris-based studio develops wellness apps designed to support users’ daily routines rather than monetise attention.

Rocapine said it has already achieved five hits across women’s health, addiction therapy and nutrition.

Its apps include Harmony, which focuses on cycle tracking and women’s wellbeing; That Girl, which supports daily habit building; and Unchaind, which helps users address compulsive behaviours.

Non-gaming app revenue surpassed mobile gaming for the first time in 2025 at US$86bn globally, according to Sensor Tower data cited by the company.

The company said wellness is one of the fastest-growing segments, driven mainly by rising demand from younger generations.

Alexandre Glaser, investment director at Educapital, said: “Rocapine is one of the most compelling stories we have seen in European consumer tech. In less than a year, the team has done what most studios take years to attempt: build multiple hits, crack distribution and generate real revenue at speed. What strikes us most is their rare combination of product instinct and execution velocity.”

“The best consumer products earn trust by improving people’s lives,” said Jean-Charles Samuelian-Werve, co-founder and chief executive of Alan, and early investor in Rocapine.

“That’s exactly what Rocapine does, using AI to craft deeply personalised wellness apps and scale them faster than anyone in the space. They’ve built multiple hits in under a year while staying true to a mission that matters.”

Rocapine said it is using a high-velocity publisher model for consumer wellness apps, based on testing many concepts before scaling a smaller number.

It said methods used in mobile gaming, including rapid testing, AI-native development and performance marketing, can be applied to wellness apps.

AI, or artificial intelligence, refers to software that can analyse data, identify patterns and support tasks such as personalisation.

Rather than focusing on a single app, Rocapine tests hundreds of concepts each year, often with independent developers.

When a concept shows user demand, the company said it can develop and scale a personalised wellness app using its AI-native technology stack.

The company said one of its apps reached US$1m ARR 16 days after launch.

Rocapine said the new funding will help turn its early apps into category leaders, scale its testing engine to 400 apps this year and strengthen its AI, data and marketing infrastructure.

Paul Bazin, partner at Daphni, said: “People are waking up to what their screens are costing them, and they want tools that serve them, not exploit them. In just 18 months, Rocapine has built one of the most powerful AI engines for shipping high-quality apps at record speed, with a model that gets smarter with every test. The next generation of category leaders in wellness will come from them.”

The Series A round was led by Educapital, with participation from Daphni, Ring Capital, Centre Court Capital, Athletico Ventures and Better Angle.

Rocapine is backed by founders and leaders from health, consumer apps and mobile gaming.

They include Jean-Charles Samuelian of Alan, Sacha Lazimi, Marc-Antoine Durand and Jérémie Aouate of Yubo, Xavier Mariani of Adikteev, Kenneth Schlenker of Opal, Francescu Santoni of Mojo, Benedict Kurz of Knowunity, Olivier Lemarié of Photoroom, Maxime Demeure of Madbox, Maud Pasturaud of Menoclinic and Bumble, Naveen Mewani of Homa and Sebastien Borget of The Sandbox.

Rocapine is also backed by entrepreneurs including Thibaud Elzière, Amaury Sépulchre and Quentin Nickmans of Hexa, Julien Romanetto of Arianee, Gary Anssen of Alltricks, Justine Hutteau of Respire and Will Mahon of Outpost.

Pharmacist hands a green-cross medical bag to a customer at a pharmacy counter.HSE and System C deal to complete Ireland rollout
Female doctor in a white coat uses a tablet while reviewing medical data on wall-mounted screens in a modern hospital hallway.Accenture to acquire Alfahealth in Italy